Dr. Adkinson answers the question: 'Tests To Determine A Drug Allergy?' — -- Question: What tests are used to determine if I have a drug allergy? Answer: First of all, the most important test of ...

Please provide your email address to receive an email when new articles are posted on . 63.6% of patients consulted for drug allergy were recommended for more testing. 32.5% of these patients did not ...

More than 20% of the population is suspected to have a penicillin allergy, yet less than 5% have this allergy. Because a recorded "penicillin allergy" entails altered antibiotic management, risk for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Most drug allergy labels persist due to limited access ...

The drug, Palforzia, also comes with "potentially serious side effects." A drug designed to minimize the frequency and severity of a child's allergic reaction to peanuts was approved Friday by the U.S ...

The U.S. Food and Drug Administration on Friday approved the first drug to treat people with potentially deadly food allergies. Xolair, an injection, is now available to adults and children 1 year and ...

Omalizumab, currently used to treat asthma, has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, ...

NPR's Patricia Neighmond reports on efforts by one of the nation's largest insurance companies to get three allergy drugs reclassified as non-prescription. Wellpoint Health Networks succeeded today in ...

Laura Pleasants doesn’t leave her house without at least six EpiPens — autoinjectors about the size and shape of a whiteboard marker that contain medication that can calm a body’s allergic reaction.

The first antihistamine that the Food and Drug Administration approved was diphenhydramine. The compound was created in 1943, and the Parke-Davis pharmaceutical company brought it to market in 1946 ...

The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.